🇺🇸 Chlorophyllin in United States

42 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 42

Most-reported reactions

1. Drug Ineffective — 5 reports (11.9%)
2. Fatigue — 5 reports (11.9%)
3. Nausea — 5 reports (11.9%)
4. Pruritus — 5 reports (11.9%)
5. Anxiety — 4 reports (9.52%)
6. Depression — 4 reports (9.52%)
7. Vomiting — 4 reports (9.52%)
8. Weight Increased — 4 reports (9.52%)
9. Balance Disorder — 3 reports (7.14%)
10. Cellulitis — 3 reports (7.14%)

Source database →

Frequently asked questions

Is Chlorophyllin approved in United States?

Chlorophyllin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Chlorophyllin in United States?

Tata Memorial Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.